Management
-
Kevin Harter, CEO
Successful serial entrepreneur, substantial operating and business development experience, successful fund-raising history.
Chief Innovation Officer, Penn State College of Medicine; CEO, Saladax Biomedical; Co-Founder/SVP, Life Sciences Greenhouse; Co-Founder/COO, Keystone Medical Systems.
-
Scott Willett, Ph.D., Chief Technology Officer
30+ years developing processes for clinical and commercial manufacture of recombinant proteins, including 5 years at Amgen.
Led development and manufacturing of PRM-151 (recombinant human pentraxin-2) over a 14-year span at Promedior, Inc. from early discovery through Phase III clinical testing resulting in sale of the company to Roche/Genentech.
-
Jeremy Middleton, Chief Business Officer
35 years of biopharmaceutical executive experience holding senior leadership roles at large and entrepreneurial companies.
His experience includes: Elusys Therapeutics, Valera Pharmaceuticals, Neose Technologies; Global Product Director for Humira - developed strategic plan that led to Abbott acquisition.
Board of Directors
Andy Agrawal, JD, Director
LinkedIn
Seasoned operator and advisor with more than 35 years of experience in both the public and private sector with a focus on healthcare and technology.
Involved in various organizations and boards.
Tim Pelura, PhD, Director and PI, NIH STTR grants
LinkedIn
Serial life science entrepreneur with over 40 years of experience in the life science industry and has been pivotal in the development of several new therapies spanning numerous therapeutic areas.
Involved in several non-profit, regional and national life science initiative and served on the boards of several biotech organizations.
Michele Washko, Director
LinkedIn
Experienced biotech operator and advisor with nearly 25 years’ experience working for or advising enterprises of various types and sizes, ranging from startups to the Fortune 100.
Served on the boards of numerous young biotech firms and non-profit organizations and longtime member of the Corporate Faculty at Harrisburg University of Science and Technology teaching graduate courses in healthcare economics.
Respana’s Founders and Scientific Advisory Board
Zissis C. Chroneos, PhD - Founder
Department of Pediatrics, Microbiology and Immunology, Pulmonary Immunology and Physiology Laboratory, Penn State College of Medicine https://pennstate.pure.elsevier.com/en/persons/zissis-chroneos
Neil Christensen, PhD - Founder
Professor of Pathology, and Microbiology and Immunology, Associate Chief of Experimental Pathology, Medical Director, Jake Gittlen Cancer Research Foundation, Penn State College of Medicine https://pennstate.pure.elsevier.com/en/persons/neil-christense
Lester Kobzik, M.D.
Pulmonary pathologist with expertise in lung host defense and infections, including evaluation of immunomodulators in pre-clinical models of influenza and other pneumonias. Professor of Pathology (Emeritus) at Harvard Medical School and currently serves as Chief Medical Officer at Cellecta, Inc in Mountain View, CA
Sheetal Gandhotra, M.D.
Dr. Sheetal Gandotra is a Pulmonary and Critical Care physician in Birmingham, AL and is affiliated with UAB Hospital. She received her medical degree from Saba University School of Medicine and has been in practice since completing fellowship in 2018. She specializes in pulmonary and critical care medicine, including procedures such as bronchoscopy and EBUS
Mel Billingsley, PhD
Former CEO, of Life Sciences Greenhouse of Central PA. Professor Emeritus of Pharmacology at Pennsylvania State University Milton S. Hershey College of Medicine, and former Professor of Biotechnology and Entrepreneurship, Penn State (Harrisburg)